UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values

Diagnostic microbiology and infectious disease, 2015-08, Vol.82 (4), p.303-313

2015

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species

Diagnostic microbiology and infectious disease, 2015-04, Vol.81 (4), p.259-263

2015

Link zum Volltext

Verfügbarkeit prüfen

Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)

Diagnostic microbiology and infectious disease, 2016-06, Vol.85 (2), p.200-204

2016

Link zum Volltext

Verfügbarkeit prüfen

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

Diagnostic microbiology and infectious disease, 2004-03, Vol.48 (3), p.201-205

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values

Diagnostic microbiology and infectious disease, 2012-08, Vol.73 (4), p.365-368

2012

Link zum Volltext

Verfügbarkeit prüfen

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

Diagnostic microbiology and infectious disease, 2010-11, Vol.68 (3), p.278-283

2010

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017–2018

Diagnostic microbiology and infectious disease, 2020-05, Vol.97 (1), p.115007-115007, Article 115007

2020

Link zum Volltext

Verfügbarkeit prüfen

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans , and Aspergillus fumigatus : application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

Diagnostic microbiology and infectious disease, 2011, Vol.69 (1), p.45-50

2011

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years

Diagnostic microbiology and infectious disease, 2021-11, Vol.101 (3), p.115473-115473, Article 115473

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 Systemically active antifungal agents when tested against Candida spp

Diagnostic microbiology and infectious disease, 2014-06, Vol.79 (2), p.198-204

2014

Link zum Volltext

Verfügbarkeit prüfen

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents

Diagnostic microbiology and infectious disease, 2004-02, Vol.48 (2), p.101-105

2004

Link zum Volltext

Verfügbarkeit prüfen

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States

Diagnostic microbiology and infectious disease, 1999-04, Vol.33 (4), p.217-222

1999

Link zum Volltext

Verfügbarkeit prüfen

National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

Diagnostic microbiology and infectious disease, 1998-05, Vol.31 (1), p.327-332

1998

Link zum Volltext

Verfügbarkeit prüfen

International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents

Diagnostic microbiology and infectious disease, 1999-09, Vol.35 (1), p.19-25

1999

Link zum Volltext

Verfügbarkeit prüfen

National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

Diagnostic microbiology and infectious disease, 1998-02, Vol.30 (2), p.121-129

1998

Link zum Volltext

Verfügbarkeit prüfen

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method

Diagnostic microbiology and infectious disease, 2011-11, Vol.71 (3), p.252-259

2011

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi

Diagnostic microbiology and infectious disease, 1998-04, Vol.30 (4), p.251-255

1998

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method

Diagnostic microbiology and infectious disease, 2011-10, Vol.71 (2), p.167-170

2011

Link zum Volltext

Verfügbarkeit prüfen

In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs

Diagnostic microbiology and infectious disease, 2003-04, Vol.45 (4), p.241-244

2003

Link zum Volltext

Verfügbarkeit prüfen

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods

Diagnostic microbiology and infectious disease, 1999-02, Vol.33 (2), p.75-80

1999

Link zum Volltext

Verfügbarkeit prüfen

Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program

Diagnostic microbiology and infectious disease, 2009-09, Vol.65 (1), p.27-34

2009

Link zum Volltext

Verfügbarkeit prüfen

Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods

Diagnostic microbiology and infectious disease, 2010-05, Vol.67 (1), p.56-60

2010

Link zum Volltext

Verfügbarkeit prüfen

Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp

Diagnostic microbiology and infectious disease, 1998-09, Vol.32 (1), p.33-37

1998

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B

Diagnostic microbiology and infectious disease, 1998-11, Vol.32 (3), p.223-227

1998

Link zum Volltext

Verfügbarkeit prüfen

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp

Diagnostic microbiology and infectious disease, 2009-02, Vol.63 (2), p.233-236

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieDiagnostic Microbiology And Infectious Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Infectious Diseases
(39)
Life Sciences & Biomedicine
(38)
Microbiology
(38)
Science & Technology
(38)
Biological And Medical Sciences
(33)
Humans
(33)
Antifungal Agents - Pharmacology
(31)
Medical Sciences
(26)
Microbial Sensitivity Tests
(26)
Candida - Drug Effects
(25)
Fundamental And Applied Biological Sciences. Psychology
(24)
Mycology
(23)
Candida
(14)
Drug Resistance, Fungal
(13)
Infectious Disease
(13)
Internal Medicine
(13)
Antifungal Agents
(12)
Fluconazole - Pharmacology
(12)
Miscellaneous
(12)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(11)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(41)
IngentaConnect Journals
(41)
Elsevier ScienceDirect Journals Complete
(41)
MEDLINE
(38)
IngentaConnect Journals
(15)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values

In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species

Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017–2018

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans , and Aspergillus fumigatus : application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years

Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 Systemically active antifungal agents when tested against Candida spp

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States

National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents

National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method

In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method

In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods

Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program

Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods

Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp

Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp

Aktive Filter

Suchergebnisse filtern